关注
GAETANO FACCHINI
GAETANO FACCHINI
Director of Medical Oncology Unit - ASL Napoli 2 Nord - Pozzuoli-Ischia
在 aslnapoli2nord.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience.
F Diurno, FG Numis, G Porta, F Cirillo, S Maddaluno, A Ragozzino, ...
European Review for Medical & Pharmacological Sciences 24 (7), 2020
3922020
Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients
A Ottaiano, R Franco, A Aiello Talamanca, G Liguori, F Tatangelo, ...
Clinical cancer research 12 (9), 2795-2803, 2006
2512006
Microbiota effects on cancer: from risks to therapies
D Rea, G Coppola, G Palma, A Barbieri, A Luciano, P Del Prete, ...
Oncotarget 9 (25), 17915, 2018
1922018
Epithelial-mesenchymal transition in prostate cancer: an overview
M Montanari, S Rossetti, C Cavaliere, C D'Aniello, MG Malzone, ...
Oncotarget 8 (21), 35376, 2017
1902017
Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey
M Berretta, C Della Pepa, P Tralongo, A Fulvi, F Martellotta, A Lleshi, ...
Oncotarget 8 (15), 24401, 2017
1802017
Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive …
KN Chi, A Protheroe, A Rodríguez-Antolín, G Facchini, H Suttman, ...
The Lancet Oncology 19 (2), 194-206, 2018
1762018
Systemic immune-inflammation index predicts the clinical outcome in patients with mCRPC treated with abiraterone
C Lolli, O Caffo, E Scarpi, M Aieta, V Conteduca, F Maines, E Bianchi, ...
Frontiers in pharmacology 7, 376, 2016
1612016
Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: ten-year follow-up of a large series
S Del Prete, M Caraglia, D Russo, G Vitale, G Giuberti, M Marra, ...
Thyroid 12 (9), 815-821, 2002
1532002
Micrornas in prostate cancer: an overview
D Vanacore, M Boccellino, S Rossetti, C Cavaliere, C D'Aniello, ...
Oncotarget 8 (30), 50240, 2017
1422017
Toll-like receptors and COVID-19: a two-faced story with an exciting ending
L Onofrio, M Caraglia, G Facchini, V Margherita, SD Placido, C Buonerba
Future science OA 6 (8), FSO605, 2020
1212020
Ovarian cancer standard of care: are there real alternatives?
C Della Pepa, G Tonini, C Pisano, M Di Napoli, SC Cecere, R Tambaro, ...
Chinese journal of cancer 34, 17-27, 2015
1172015
Chemotherapy in epithelial ovarian cancer
S Pignata, L Cannella, D Leopardo, C Pisano, GS Bruni, G Facchini
Cancer letters 303 (2), 73-83, 2011
1172011
First-line treatment of advanced ovarian cancer: current research and perspectives
C Marchetti, C Pisano, G Facchini, GS Bruni, FP Magazzino, S Losito, ...
Expert review of anticancer therapy 10 (1), 47-60, 2010
1082010
Extragonadal germ cell tumors: not just a matter of location. A review about clinical, molecular and pathological features
A Ronchi, I Cozzolino, M Montella, I Panarese, F Zito Marino, S Rossetti, ...
Cancer medicine 8 (16), 6832-6840, 2019
1072019
Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer
C D'alterio, C Consales, M Polimeno, R Franco, L Cindolo, L Portella, ...
Current cancer drug targets 10 (7), 772-781, 2010
1072010
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study
AO Siefker-Radtke, A Necchi, SH Park, J García-Donas, RA Huddart, ...
The Lancet Oncology 23 (2), 248-258, 2022
1052022
Clinical outcomes of castration-resistant prostate cancer treatments administered as third or fourth line following failure of docetaxel and other second-line treatment …
O Caffo, U De Giorgi, L Fratino, D Alesini, V Zagonel, G Facchini, ...
European urology 68 (1), 147-153, 2015
982015
Angiogenesis inhibitors for the treatment of hepatocellular carcinoma
M Berretta, L Rinaldi, F Di Benedetto, A Lleshi, V De Re, G Facchini, ...
Frontiers in Pharmacology 7, 428, 2016
862016
Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non–small-cell lung cancer
RV Iaffaioli, A Tortoriello, G Facchini, F Caponigro, M Gentile, N Marzano, ...
Journal of clinical oncology 17 (3), 921-921, 1999
861999
Resveratrol in cancer patients: from bench to bedside
M Berretta, A Bignucolo, R Di Francia, F Comello, G Facchini, ...
International journal of molecular sciences 21 (8), 2945, 2020
832020
系统目前无法执行此操作，请稍后再试。
文章 1–20